The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Haque, Kemal, Dr
    Director born in April 1969
    Individual (3 offsprings)
    Officer
    2019-10-22 ~ now
    OF - Director → CIF 0
    Dr Kemal Haque
    Born in April 1969
    Individual (3 offsprings)
    Person with significant control
    2019-10-22 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 2
    Sparksman, Caitlin
    Director born in April 1971
    Individual (1 offspring)
    Officer
    2019-10-22 ~ now
    OF - Director → CIF 0
    Mrs Caitlin Sparksman
    Born in April 1971
    Individual (1 offspring)
    Person with significant control
    2019-10-22 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

OKTEM BIOPHARMA CONSULTING LTD

Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Average Number of Employees
22022-11-01 ~ 2023-10-31
22021-11-01 ~ 2022-10-31
Property, Plant & Equipment
519 GBP2023-10-31
880 GBP2022-10-31
Debtors
Current
8,461 GBP2023-10-31
6,648 GBP2022-10-31
Cash at bank and in hand
70,523 GBP2023-10-31
99,988 GBP2022-10-31
Current Assets
78,984 GBP2023-10-31
106,636 GBP2022-10-31
Creditors
Current, Amounts falling due within one year
-15,014 GBP2023-10-31
-20,471 GBP2022-10-31
Net Current Assets/Liabilities
63,970 GBP2023-10-31
86,165 GBP2022-10-31
Total Assets Less Current Liabilities
64,489 GBP2023-10-31
87,045 GBP2022-10-31
Net Assets/Liabilities
64,359 GBP2023-10-31
86,878 GBP2022-10-31
Equity
Called up share capital
2 GBP2023-10-31
2 GBP2022-10-31
Retained earnings (accumulated losses)
64,357 GBP2023-10-31
86,876 GBP2022-10-31
Equity
64,359 GBP2023-10-31
86,878 GBP2022-10-31
Property, Plant & Equipment - Depreciation rate used
Office equipment
332022-11-01 ~ 2023-10-31
Property, Plant & Equipment - Gross Cost
Other
3,134 GBP2023-10-31
2,885 GBP2022-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
2,615 GBP2023-10-31
Property, Plant & Equipment
Other
519 GBP2023-10-31
880 GBP2022-10-31
Trade Debtors/Trade Receivables
Current
8,188 GBP2023-10-31
6,306 GBP2022-10-31
Prepayments/Accrued Income
Current
273 GBP2023-10-31
342 GBP2022-10-31
Corporation Tax Payable
Current
4,168 GBP2023-10-31
10,312 GBP2022-10-31
Taxation/Social Security Payable
Current
1,334 GBP2023-10-31
872 GBP2022-10-31
Accrued Liabilities/Deferred Income
Current
9,512 GBP2023-10-31
9,287 GBP2022-10-31
Creditors
Current
15,014 GBP2023-10-31
20,471 GBP2022-10-31
Net Deferred Tax Liability/Asset
-130 GBP2023-10-31
-167 GBP2022-10-31
-323 GBP2021-11-01
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
37 GBP2022-11-01 ~ 2023-10-31
156 GBP2021-11-01 ~ 2022-10-31
Deferred Tax Liabilities
Accelerated tax depreciation
-130 GBP2023-10-31
-167 GBP2022-10-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
2 shares2023-10-31
2 shares2022-10-31
Par Value of Share
Class 1 ordinary share
1.002022-11-01 ~ 2023-10-31

  • OKTEM BIOPHARMA CONSULTING LTD
    Info
    Registered number 12274031
    Tennyson House, Cambridge Business Park, Cambridge CB4 0WZ
    Private Limited Company incorporated on 2019-10-22 (5 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-21
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.